Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sterofundin vs Normal Saline in Shock
NCT02520804Unknown
- Sponsor
- Mahidol University
- Start
- Nov 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sterofundin in Shock (2 arms), sponsored by Mahidol University. Primary endpoint: Acute Kidney Injury Incidence at 7 days. Status: unknown.
02
Drugs
sterofundin
03
Conditions
Shock
Beyond the preview
Go deeper on NCT02520804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02520804.